Certara Announces New Versions of Biosimulation Software for Development of Novel Biologics
June 21, 2022 08:00 ET
|
Certara
PRINCETON, N.J., June 21, 2022 (GLOBE NEWSWIRE) -- Certara Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the release of new versions of its Immunogenicity (IG),...
SomaLogic Announces New Collaboration with FDA to Advance Biosimilar Development
October 29, 2020 10:00 ET
|
SomaLogic, Inc.
BOULDER, Colo., Oct. 29, 2020 (GLOBE NEWSWIRE) -- SomaLogic, Inc. announced today an agreement with the US Food and Drug Administration (FDA)’s Division of Applied Regulatory Science to evaluate the...
Biosimilars Market To Reach USD 44.56 Billion By Year 2026 | Reports And Data
March 19, 2019 11:34 ET
|
Reports And Data
Market Size – USD 5.10 Billion in 2018, Market Growth - CAGR of 30.8%, Market Trends – Product launches and research for advanced Biosimilars NEW YORK, March 19, 2019 (GLOBE NEWSWIRE) -- ...